Pharmacokinetics of SCH 56592, a New Azole Broad-Spectrum Antifungal Agent, in Mice, Rats, Rabbits, Dogs, and Cynomolgus Monkeys

SCH 56592 is a new broad-spectrum azole antifungal agent that is in phase 3 clinical trials for the treatment of serious systemic fungal infections. The pharmacokinetics of this drug candidate were evaluated following its intravenous (i.v.) or oral (p.o.) administration as a solution in hydroxypropy...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nomeir, Amin A., Kumari, Pramila, Hilbert, Mary Jane, Gupta, Samir, Loebenberg, David, Cacciapuoti, Anthony, Hare, Roberta, Miller, George H., Lin, Chin-Chung, Cayen, Mitchell N.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2000
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC89754/
https://ncbi.nlm.nih.gov/pubmed/10681346
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky